Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin-Positive SQSTM1 Bodies.

Genes to cells : devoted to molecular & cellular mechanisms·2026
Same author

Investigation of early axonal phenotypes in an iPSC-derived ALS cellular model using a microfluidic device.

Frontiers in cellular neuroscience·2025
Same author

Soymilk yogurt prepared using <i>Pediococcus pentosaceus</i> TOKAI 759m ameliorates cognitive function through gut microbiota modulation in high-fat diet mice.

Current research in food science·2025
Same author

Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegias.

Drug discovery today·2024
Same author

Rare <i>CRHR2</i> and <i>GRM8</i> variants identified as candidate factors associated with eating disorders in Japanese patients by whole exome sequencing.

Heliyon·2024
Same author

Effect of PCDH19 missense mutations on cell-to-cell proximity and neuronal development under heterotypic conditions.

PNAS nexus·2024

Related Experiment Video

Updated: Jul 17, 2026

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
08:57

Aip1p Dynamics Are Altered by the R256H Mutation in Actin

Published on: July 30, 2014

ALS2CL, a novel ALS2-interactor, modulates ALS2-mediated endosome dynamics.

Kyoko Suzuki-Utsunomiya1, Shinji Hadano, Asako Otomo

  • 1Department of Molecular Neuroscience, The Institute of Medical Sciences, Tokai University, Kanagawa, Japan.

Biochemical and Biophysical Research Communications
|January 24, 2007
PubMed
Summary

A novel ALS2 homolog, ALS2CL, interacts with ALS2, forming a complex that modulates endosome dynamics. This interaction suppresses ALS2-induced endosome enlargement, impacting motor neuron disease pathways.

More Related Videos

Expanding the Toolkit for In Vivo Imaging of Axonal Transport
09:24

Expanding the Toolkit for In Vivo Imaging of Axonal Transport

Published on: December 23, 2021

In vivo and in vitro Studies of Adaptor-clathrin Interaction
17:14

In vivo and in vitro Studies of Adaptor-clathrin Interaction

Published on: January 26, 2011

Related Experiment Videos

Last Updated: Jul 17, 2026

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
08:57

Aip1p Dynamics Are Altered by the R256H Mutation in Actin

Published on: July 30, 2014

Expanding the Toolkit for In Vivo Imaging of Axonal Transport
09:24

Expanding the Toolkit for In Vivo Imaging of Axonal Transport

Published on: December 23, 2021

In vivo and in vitro Studies of Adaptor-clathrin Interaction
17:14

In vivo and in vitro Studies of Adaptor-clathrin Interaction

Published on: January 26, 2011

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Neuroscience

Background:

  • Amyotrophic lateral sclerosis type 2 (ALS2) is linked to motor neuron diseases and regulates endosome dynamics via Rab5.
  • A novel ALS2 homolog, ALS2CL, shares homology with ALS2 and is investigated for its role in cellular processes.

Purpose of the Study:

  • To investigate the molecular features of ALS2CL.
  • To elucidate the functional relationship between ALS2CL and ALS2.
  • To understand ALS2CL's role in ALS2-mediated endosome dynamics.

Main Methods:

  • Investigated ALS2CL homo-dimerization and interaction with ALS2 oligomers.
  • Analyzed co-localization of overexpressed ALS2CL and ALS2 in cultured cells.
  • Assessed the effect of ALS2CL on ALS2-induced endosome enlargement and cellular phenotype.

Main Results:

  • ALS2CL forms homo-dimers and interacts with ALS2 oligomers, creating a large ALS2/ALS2CL heteromeric complex.
  • Overexpressed ALS2CL co-localizes with ALS2 on membranous compartments in cultured cells.
  • ALS2CL suppresses ALS2-induced endosome enlargement and induces a perinuclear tubulo-membranous phenotype, dependent on ALS2CL-ALS2 interaction.

Conclusions:

  • ALS2CL is a novel ALS2-interacting protein.
  • ALS2CL plays a role in modulating ALS2-mediated endosome dynamics.
  • The ALS2CL-ALS2 interaction is crucial for regulating endosome morphology and cellular phenotype.